|
NEW! Follow us on
 
Advertisement
|
 |
| Editor's Notebook |
Getting a Read on Sunscreen
As with most healthcare topics, there is a lot more to sunscreen than meets the eye, including how to navigate the morass of marketing hype and really understand the nuances of sun-protection products. |
|
| Counseling Pearls |
 Insect Repellents for Zika Virus Prevention
Prevention of Zika virus is imperative, as there is currently no vaccine or specific treatment. In addition to practicing exposure avoidance and using physical barriers, persons at risk should also apply topical mosquito repellents and insecticides for optimal protection. |
 Updates in the Management of Seasonal Allergic Rhinitis
Allergic rhinitis, often called hay fever, is an inflammatory response to an allergen that is mediated by immunoglobulin E. At this time, intranasal corticosteroids and oral antihistamines remain the mainstay of treatment for allergies. |
| |
| Senior Care |
Systemic Corticosteroid–Associated Psychiatric Adverse Effects
Use of corticosteroids in the treatment of respiratory diseases and other common conditions in older adults can cause disturbances of mood, cognition, sleep, behavior, and even delirium or psychosis. |
| |
| Clinical Corner |
 Reducing Inappropriate Antibiotic Prescribing for Acute Respiratory Tract Infections
Pharmacists can play a unique role in educating patients and providers about the impact of inappropriate prescribing, making alternative nonprescription recommendations to providers and patients who are seeking options for symptom alleviation, and working at the forefront of antibiotic stewardship efforts. |
 Antimicrobial Therapy for Hospital-Acquired Pneumonia
Hospital-acquired pneumonia (HAP) is a commonly encountered infection in the inpatient setting. Challenges to the appropriate management of HAP include delayed diagnosis, inappropriate empiric treatment, presence of multidrug-resistant pathogens, and emergence of antimicrobial resistance. |
| |
| Consult Your Pharmacist |
Avoiding Sunburn: All About Sunscreen
There are many other factors to consider when choosing or recommending a sunscreen product to patients. Some of these include the product's SPF, broad-spectrum coverage, and water resistance. |
| |
| Educational Spotlight |
Overview of Plaque Psoriasis Treatment
Treatment consists of a variety of options, including phototherapy, topical agents, oral agents, and biologics. |
Safe Use of Analgesics in Acute Pediatric Pain
Pharmacists play an integral role in ensuring that pain medications are used properly and safely in children. |
Herpes Zoster: Counseling Patients About Prevention and Treatment
Pharmacologic management aims to treat the patient's clinical manifestations of shingles. |
| |
|
|
| Newswire |
 |
Humira Biosimilar Backed by FDA Panel
Silver Spring, MD—
The FDA's Arthritis Advisory Committee has recommended a biosimilar version of AbbVie's Humira (adalimumab). The panel voted unanimously in favor of licensing ABP 501, the biosimilar of Humira from Amgen. The blockbuster biologic Humira is approved for the treatment of several automimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. To date, the FDA has approved two biosimilars (Zarxio and Inflectra), with several others, including one for Enbrel, pending review. The FDA does not necessarily have to follow the panel's recommendation, and a final decision on the approval of the agent will be made by September. |
|
Vaginal Ring Reduces Transmission of HIV
Durban, South Africa—
Data presented at the AIDS 2016 conference show that the dapivirine vaginal ring provides significant protection against HIV infection in women. New analyses of two large phase III clinical trials in Africa (The Ring Study and ASPIRE) found that HIV risk was cut by at least 56% in women who used the monthly ring consistently. Based on these results, two open-label studies are being launched to provide an assessment of "real world" usage. Despite advances in antiretroviral therapy and preexposure prophylaxis (PrEP), HIV continues to spread among women in sub-Saharan Africa at alarming rates. |
|
Acne Medication Approved for Rx-to-OTC Switch
Silver Spring, MD—
The FDA has approved Differin Gel 0.1% (adapalene; Galderma Laboratories), a once-daily topical gel for the OTC treatment of acne. It contains the first new active ingredient for nonprescription acne therapy since the 1980s, and it is also the first retinoid to be made available OTC for this use. The product was originally approved in 1996 as a prescription drug for the treatment of acne vulgaris in patients aged ≥12 years. To support approval for OTC marketing, data from 1996-2016 postmarketing safety and consumer use studies were submitted. Acne is very common and affects approximately 50 million people in the United States. |
|
|
  |
| To subscribe to e-Connect, send your name, address, and email address to us by clicking here.
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. |
|
|
